New rating for NorthX Biologics in International Sustainability Survey

We are proud to inform you that NorthX Biologics improved its score from bronze to silver in the International Sustainability Survey (EcoVadis) for the year 2022. We have also implemented more routines and policies at our company to continuously improve the way we operate.

EcoVadis provides holistic sustainability rating services of companies. The rating covers a broad range of non-financial management systems including environmental, labor & human rights, ethics, and sustainable procurement impacts. NorthX has been rated on the material issues that are relevant to our company’s size, location, and industry.

It is important as a company to manage sustainability risks, and the Pharma industry is no exception. Our goal is to provide sustainable process development and manufacturing services at our company.

If we look closer at the environmental area, we have improved our preventive work such as decreasing our impact on the environment and the municipality’s treatment plant. We now know more about the characteristics of our wastewater and how to handle our hazardous waste which gives us a better chance to improve and become more sustainable.

In the ethics area, we also have improved our preventative work such as implementing policies on information security, ethics issues and corruption. It is important to us that we also have a sustainable production and use raw materials that have been ethically made.

It is also important for us to have good work health and equality. At NorthX we have good diversity, equity, and inclusion of all employees. It is important that our employees stay safe and healthy for a sustainable workplace. We do preventive workthrough risk assessment, information sharing, and education.

We thank all of our employees for the work they have done for this rating and look forward to continuing our improvements in these areas in order to progress in the survey.

About NorthX Biologics AB

NorthX Biologics is a CDMO and Innovation Hub in Advanced Biologics, with +30 years of GMP production experience. The team provides process development and GMP manufacturing services with expertise in plasmid DNA, mRNA, proteins, cells and other advanced biologics. Headquartered in the heart of Sweden, the team serves customers worldwide and in 2021 was recognized as a national innovation hub for advanced therapeutics and vaccines. NorthX has the ambition to become a leading cell and gene therapy manufacturer and partner of choice for innovative drug development companies.

For more news, follow us on

LinkedIn